Literature DB >> 10733739

Is there a role for autoimmunity in immune protection against malaria?

C T Daniel-Ribeiro1.   

Abstract

Much remains to be known about the mechanisms involved in protective immunity against malaria and the way it is acquired. This is probably the reason why, in spite of so much progress, it has not yet been possible to develop an anti-malaria vaccine able to induce parasite specific antibodies (Ab) and/or T-cells. It has been considered in the early 80s that the induction of efficient protection against the blood stage forms of Plasmodium falciparum would not be possible without simultaneously eliciting an autoimmune (AI) response against erythrocytes, even at the price of inducing an AI pathology. Despite the description of the reciprocal relationship, i.e. the protective effect of malaria on the development of AI diseases _ demonstrated since 1970 _ no effort has been made to verify the possible involvement of the AI response in protection against malaria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733739     DOI: 10.1590/s0074-02762000000200011

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  9 in total

Review 1.  Systems biology of malaria explored with nonhuman primates.

Authors:  Mary R Galinski
Journal:  Malar J       Date:  2022-06-07       Impact factor: 3.469

2.  Testosterone persistently dysregulates hepatic expression of Tlr6 and Tlr8 induced by Plasmodium chabaudi malaria.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel-Azeem S Abdel-Baki; Marcos J Araúzo-Bravo; Denis Delic; Frank Wunderlich
Journal:  Parasitol Res       Date:  2014-07-24       Impact factor: 2.289

3.  Blood-stage malaria of Plasmodium chabaudi induces differential Tlr expression in the liver of susceptible and vaccination-protected Balb/c mice.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Suliman Alomar; Abdel Azeem S Abdel-Baki; Denis Delic; Frank Wunderlich; Marcos J Araúzo-Bravo
Journal:  Parasitol Res       Date:  2016-01-25       Impact factor: 2.289

4.  Increased polyclonal immunoglobulin reactivity toward human and bacterial proteins is associated with clinical protection in human Plasmodium infection.

Authors:  Constantin Fesel; Luis F Goulart; Adolfo Silva Neto; Alysson Coelho; Cor Jesus F Fontes; Erika M Braga; Nelson M Vaz
Journal:  Malar J       Date:  2005-01-20       Impact factor: 2.979

Review 5.  Epitopes for Protective Immunity Targeting Antigens of Pathogen and/or Host (EPITAPH): Towards Novel Vaccines Against HIV and Other Medically Challenging Infections.

Authors:  Salvador Eugenio C Caoili
Journal:  Front Immunol       Date:  2014-06-10       Impact factor: 7.561

6.  Exacerbation of autoimmune neuro-inflammation in mice cured from blood-stage Plasmodium berghei infection.

Authors:  Rodolfo Thomé; André Luis Bombeiro; Luidy Kazuo Issayama; Catarina Rapôso; Stefanie Costa Pinto Lopes; Thiago Alves da Costa; Rosária Di Gangi; Isadora Tassinari Ferreira; Ana Leda Figueiredo Longhini; Alexandre Leite Rodrigues Oliveira; Maria Alice da Cruz Höfling; Fábio Trindade Maranhão Costa; Liana Verinaud
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

7.  Liver-inherent immune system: its role in blood-stage malaria.

Authors:  Frank Wunderlich; Saleh Al-Quraishy; Mohamed A Dkhil
Journal:  Front Microbiol       Date:  2014-11-04       Impact factor: 5.640

8.  Self-reactivities to the non-erythroid alpha spectrin correlate with cerebral malaria in Gabonese children.

Authors:  Vincent Guiyedi; Youri Chanseaud; Constantin Fesel; Georges Snounou; Jean-Claude Rousselle; Pharat Lim; Jean Koko; Abdelkader Namane; Pierre-André Cazenave; Maryvonne Kombila; Sylviane Pied
Journal:  PLoS One       Date:  2007-04-25       Impact factor: 3.240

9.  Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age.

Authors:  Virginia S Baker; Godwin E Imade; Norman B Molta; Pallavi Tawde; Sunday D Pam; Michael O Obadofin; Soloman A Sagay; Daniel Z Egah; Daniel Iya; Bangmboye B Afolabi; Murray Baker; Karen Ford; Robert Ford; Kenneth H Roux; Thomas Cs Keller
Journal:  Malar J       Date:  2008-02-29       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.